Pocket K No. 8. Cartagena Protocol on Biosafety

Similar documents
Transport of Genetically Modified Micro-organisms and Organisms or Living Modified Organisms (LMOs)

Bioinformatics, in general, deals with the following important biological data:

Chapter 5. The Carriage of Genetically Modified (GM) Crops

The Biosafety Clearing-House

Pocket K No. 16. Biotech Crop Highlights in 2016

UNIDO BIOSAFETY MANUAL. Draft June /...

The Biosafety Clearing House

Rules and Regulations on GMO-derived food products in the European Union Lynn Insall UK Food and Drink Federation

Global Review of Commercialized Transgenic Crops: 2002 Feature: Bt Maize

Supplement to ISPM No. 11 (Pest risk analysis for quarantine pests) PEST RISK ANALYSIS FOR LIVING MODIFIED ORGANISMS

What is Biotechnology?

This Pocket K documents some of the GM crop experiences of selected developing countries.

GENETICALLY MODIFIED (GM) CROPS AND BIOSAFETY** Prof S.Kannaiyan*

NAGOYA KUALA LUMPUR SUPPLEMENTARY PROTOCOL ON LIABILITY AND REDRESS TO THE CARTAGENA PROTOCOL ON BIOSAFETY

Pocket K No. 42. Stacked Traits in Biotech Crops

Domestic Import Regulations for Genetically Modified Organisms and Their Compatibility with WTO Rules

GUIDANCE ON RISK ASSESSMENT OF LIVING MODIFIED ORGANISMS AND MONITORING IN THE CONTEXT OF RISK ASSESSMENT

Enhancing Africa s Capacity for Global Engagement in International Biosafety Negotiations

Pest risk analysis for quarantine pests

trade knowledge network

Regulation of Agricultural Biotechnology in the United States: Overview

Pocket K No. 2. Plant Products of Biotechnology

GMOs in South Africa Series

OECD and Substantial Equivalence Peter Kearns, OECD

ECOROPA. Potential Ecological and Social Impacts of Genetically Engineered Trees

Information as required by the Cartagena Protocol on Biosafety and the national biosafety legislation:

Issues in Agricultural Biotechnology and Biodiversity for Sustainable Agroecosystems

BIOSAFETY AND ENVIRONMENTAL ISSUES

INTERNATIONAL STANDARDS FOR PHYTOSANITARY MEASURES REVOKED. ISPM No. 2 FRAMEWORK FOR PEST RISK ANALYSIS (2007)

NATIONAL STANDARD FOR PHYTOSANITORY MEASURES. Glossary of Phytosanitary Terms

AN UPDATE ON INDIAN BIOSAFETY REGULATORY SYSTEM. Dr. Vibha Ahuja Biotech Consortium India Limited

Release into Environment of Genetically Modified Organisms Act 1

Summary of the WTO Interim Report in EC-Biotech

Beyond Promises: Facts about Biotech/GM Crops in 2016

Updates/status of the Bhutanese Biosafety Regulatory system

Regulation of Biotechnology: needs and burdens for developing Countries

In farmers fields: Ruth Raymond and Amanda Dobson, Bioversity International

Biosafety Resource Book. legal aspects

THE NATIONAL BIOSAFETY FRAMEWORK FOR RWANDA

GMO Spring Wheat: Its potential short-term impacts on U.S. wheat exports markets and prices*

Environmental monitoring plan for soybean MON 89788

ECONOMIC IMPACT STUDY: POTENTIAL COSTS OF MANDATORY LABELLING OF FOOD PRODUCTS DERIVED FROM BIOTECHNOLOGY IN CANADA

Domestic and International Access and Benefit Sharing

INTERNATIONAL LAW AND INSTITUTIONS - International Law On Biotechnology - Der-Chin Horng

Testimony of the Biotechnology Industry Organization. Submitted to the California Assembly Committee on Agriculture.

Determining Trends in Agriculture

GM Food Safety: Philippine Regulations and Food Safety Assessment

October Trends in potential GMO trade a case study for Kenya Kimani V Pesticides and Agricultural Resource Centre

PREPUBLICATION CODEX PRINCIPLES AND GUIDELINES ON FOODS DERIVED FROM BIOTECHNOLOGY CONTENTS

MONITORING AND REPORTING (ARTICLE

GLOSSARY OF PHYTOSANITARY TERMS

Environmentally sound dismantling of ships

10 Million Acres of Opportunity. Planning for a decade of sustainable growth and innovation in the Canadian soybean industry

evaluate risk / benefit implications ascertain applicability of existing legislation

APPLICATION FOR COMMODITY CLEARANCE OF GENETICALLY MODIFIED ORGANISMS (GMO)

USDA-APHIS Biotechnology Regulatory Services Janet L. Bucknall Associate Deputy Administrator

ISPM 5. Glossary of phytosanitary terms

European Genebank Network for Animal Genetic Resources

AGREEMENT ON U.S. - CHINA AGRICULTURAL COOPERATION

Access and Benefit Sharing International Agreements and Conventions

The radiata pine estate and the regulation of GM forestry trees in New Zealand. Dr. Tim Strabala, Principal Scientist, New Organisms

This document is meant purely as a documentation tool and the institutions do not assume any liability for its contents

Will developing countries adopt policies that promote the planting of genetically. Governing the GM Crop Revolution

Annex CONTENTS. Access to genetic resources and the fair and equitable sharing of benefits arising from their utilization... 85

Phytosanitary Measures and International Seed Trade. International Plant Protection Convention (IPPC)

Guidance on the EU ABS Regulation implementing the Nagoya Protocol. REGULATION (EU) No 511/2014 OF THE EUROPEAN PARLIAMENT AND OF THE COUNCIL

COUNTRY-CASE PRESENTATION: PHILIPPINES

HANDLING, TRANSPORT, PACKAGING AND IDENTIFICATION OF LIVING MODIFIED ORGANISMS

PROS AND CONS OF GMO FOODS

Regulations and safety assessment for genetically modified foods and feeds in Taiwan

Genetic Modification in Our World. By: Paisley, Michael, Blake, and Elyse

CORRESPONDENTS' GUIDELINES No 3

Building Better Algae

The Basel Convention At A Glance

Environmental Risk Assessment and Management of Living Modified Organisms(LMO)

E37. Genetically modified organisms [CIV : Federated Farmers of New Zealand Incorporated]

Fair and equitable benefit sharing

AGRICULTURE (CODE NO. 01) PAPER - I

The International Plant Protection Convention (IPPC) Guide to the Implementation of ISPMs in Forestry Core Group Meeting May 2009

The Convention on Biological Diversity is an international treaty for conservation of biological

PRIOR NOTICE OF IMPORTED FOOD SHIPMENTS

Arifin Tasrif, Ph.D. Presented on WCO Regional Workshop on Strategic Initiatives for Trade Facilitation Mercator Programme, Jakarta Mach 2015

Productivity growth in developed countries: Australia. Presentation to 2013 IATRC Symposium

STUDY GUIDE ARE GMOS GOOD OR BAD? KEY TERMS: genes DNA genetically-modified

Forest Reproductive Material Certification Standards Oregon - Washington Interagency

CANADIAN AGRI-FOOD TRADE ALLIANCE

International. Waters

IBC protocol Risk Assessment and Determination of NIH Guidelines

Genetically Modified Organisms GMO - Update on Approval, Planting and Detection

(Text with EEA relevance) Having regard to the Treaty on the Functioning of the European Union, and in particular Article 192(1) thereof,

Agricultural Outlook Forum For Release: Monday, February 23, 1998 SETTING INTERNATIONAL STANDARDS FOR FOOD AND AGRICULTURAL TRADE

Introduction to Biotechnology

Privacy Policy PURPOSE SCOPE POLICY. Data Collection

Nagoya Protocol on Access and Benefit Sharing -Technical Brief

Biosafety Regulation in Kenya

1 Introduction 2 BASF Crop Protection 3 BASF Plant Biotechnology Dr. Peter Eckes President, BASF Plant Science

CROP PRODUCTION AND BIOTECHNOLOGY: Successes and Challenges SUMMARY

Post-Market Oversight of Biotech Foods

GM Crops and Biodiversity is this solely a GM issue?

IS THE US FDA REGULATION AND EVALUATION OF GENETICALLY ENGINEEERED FOODS SUFFICIENT? Teresa Marek FOOD REGULATION IN THE UNITED STATES

Transcription:

Pocket K No. 8 Cartagena Protocol on Biosafety In 1994, the first genetically modified food crop, Calgene s Flavr-Savr tomato, was produced and consumed in an industrialized country. Since that time, genetically modified (GM) crops have been rapidly adopted worldwide reflecting the satisfaction of growers. While advances in biotechnology have great potential to improve human well-being, the technology must be developed with adequate safety measures. The Cartagena Protocol on Biosafety is a legally binding global protocol that seeks to contribute to ensuring the safe transfer, handling and use of living modified organisms (LMOs) created through modern biotechnology. MICROSOFT CORP. PHOTO USDA PHOTO What is the Protocol s objective? Article 1 of the Protocol states that it aims to contribute to ensuring an adequate level of protection in the field of the safe transfer, handling and use of living modified organisms resulting from modern biotechnology that may have adverse effects on the conservation and sustainable use of biological diversity, taking also into account risks to human health, and specifically focusing on transboundary movements. In short, it seeks to protect biodiversity from the potential risks of living modified organisms (LMOs) resulting from modern biotechnology. What does the Protocol cover? The Protocol covers the transboundary movement, transit, handling and use of all living modified organisms that may have adverse effects on the conservation and sustainable use of biological diversity, taking into account risks to human health. It does not cover: Products derived from LMOs (e.g. paper from GM trees) LMOs, which are pharmaceuticals for humans that are addressed by other relevant international agreements or organizations What is the Biosafety Protocol? The Cartagena Protocol on Biosafety is a legally binding protocol to the Convention on Biological Diversity (CBD). It was named in honor of Cartagena, Colombia, where negotiations http://www.isaaa.org/kc 1

were expected to conclude in February 1999. One year later, on January 29, 2000, the Protocol was finalized and adopted in Montreal, Canada by unanimous consent with 135 countries present. What does the Biosafety Protocol do? It assists developing countries in building their capacity for managing modern biotechnology It creates an advanced informed agreement (AIA) procedure that requires exporters to seek consent from importing countries before the first shipment of LMOs meant to be introduced into the environment (e.g. seeds for planting, fish for release, and microorganisms for bioremediation) It establishes an internet-based Biosafety Clearing-House to help countries exchange scientific, technical, environmental and legal information about LMOs. It requires bulk shipments of LMO commodities, such as corn or soybeans that are intended to be used as food, feed or for processing, to be accompanied by documentation stating that such shipments may contain LMOs and are not intended for intentional introduction into the environment. The Protocol includes a clause that makes clear the Parties intent that the agreement does not alter the rights and obligations of governments under the World Trade Organization (WTO) or other existing international agreements. What does the Biosafety Protocol NOT do? The Protocol does not address food safety issues. This is addressed by experts in other international fora. The Protocol does not require segregation of bulk shipments of commodities that may contain living modified organisms. It does not require consumer product labeling. LORI ALDEN PHOTO It does not subject shipments of bulk commodities to the Protocol s AIA procedure. http://www.isaaa.org/kc 2

Key features of the Protocol Advanced Informed Agreement (AIA) The Protocol s main mechanism is its Advanced Informed Agreement (AIA) requirement. It is a procedure that must be followed before the first intentional transboundary movement of an LMO into the environment of the importing country. The exporter must provide a notification to the importing country containing detailed information about the LMO, previous risk assessments of the LMO and its regulatory status in the exporting country. The importing country must acknowledge receiving the information within 90 days and whether the notifier should proceed under a domestic regulatory system or under the Protocol procedure. In either case, the importing country must decide whether to allow the import, with or without conditions or deny it within 270 days. What is not subject to the AIA requirement? Consecutive shipments. The Protocol s AIA only covers first time shipments. LMOs not intended for release into the environment such as commodities, LMOs in transit, and LMOs destined for contained use. USDA PHOTO Biosafety Clearing-House (BCH) The BCH is a website administered by the Secretariat to the Convention (http://bch.biodiv.org). It was established to: 1) facilitate the exchange of scientific, technical, environmental and legal information on, and experience with LMOs; and 2) assist Parties to implement the Protocol. Examples of information contained in the BCH include: any existing laws, regulations, or guidelines for implementation of the Protocol, summaries of risk assessments or environmental reviews of LMOs, and final decisions regarding the importation or release of LMOs. Risk Assessment The Protocol requires that decisions on proposed imports be based on risk assessments. Risk assessments must be undertaken in a scientific manner based on recognized risk assessment techniques, taking into account advice and guidelines developed by relevant international organizations. Lack of scientific knowledge or scientific consensus must not necessarily be interpreted as indicating a particular level or risk, an absence or risk, or an acceptable risk. Risks associated with LMOs or products thereof should be considered in the context of risks posed by the non-modified recipients or parental organisms in the likely potential receiving environment. Risk assessment should be carried out on a case by case basis. http://www.isaaa.org/kc 3

Capacity Building The Protocol promotes international cooperation to help developing countries acquire resources and capacity to use biotechnology safely and regulate it efficiently. It does this by encouraging member governments to assist with scientific and technical training to promote the transfer of technology, knowledge and financial resources. Governments are also expected to facilitate greater involvement of the private sector. Public Awareness Member governments must commit themselves to promoting public awareness, insuring public access to information, and public consultation. The Protocol recognizes that national measures are important to make its procedures effective. Nations must also take measures to prevent illegal shipments or accidental releases of LMOs. List of Terms Living modified organism (LMO) Any living organism that possesses a novel combination of genetic material obtained through the use of modern biotechnology Modern biotechnology The application of a) In vitro nucleic acid techniques, including recombinant deoxyribonucleic acid (DNA) and direct injection of nucleic acid into cells or organelles or b) Fusion of cells beyond the taxonomic family, that overcome natural physiological reproductive or recombination barriers and that are not techniques used in traditional breeding and selection. (http://www.biodiv.org/biosafety/protocol.asp) Useful websites Biosafety Protocol (http://www.biodiv.org/biosafety) Biosafety Clearing House (http://bch.biodiv.org/pilot) http://www.isaaa.org/kc 4

Pocket Ks are Pockets of Knowledge, packaged information on crop biotechnology products and related issues available at your fingertips. They are produced by the Global Knowledge Center on Crop Biotechnology (http://www.isaaa.org/kc). For more information, please contact the International Service for the Acquisition of Agribiotech Applications (ISAAA) SEAsiaCenter c/o IRRI, DAPO Box 7777, Metro Manila, Philippines Tel: +63 2 845 0563 Fax: +63 2 845 0606 E-mail:knowledge.center@isaaa.org Revised July 2004 http://www.isaaa.org/kc 5